Maybe clearing their current ongoing SB royalty commitments, to put them in a more favourable position to negotiate sale of SB/BOT to other potential pharmaceutical companies looking to acquire them.
Other pharmaceutical companies wouldn’t want to buy the business with the obligation of paying ongoing royalties on a growing business.
?
- Forums
- ASX - By Stock
- BOT
- Ann: Trading Halt
Ann: Trading Halt, page-26
-
- There are more pages in this discussion • 183 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
40.8¢ |
Change
-0.008(1.81%) |
Mkt cap ! $737.5M |
Open | High | Low | Value | Volume |
40.0¢ | 41.5¢ | 40.0¢ | $2.905M | 7.133M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 1400486 | 40.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
41.0¢ | 471154 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 1459213 | 0.405 |
25 | 607162 | 0.400 |
15 | 846406 | 0.395 |
12 | 912079 | 0.390 |
9 | 681573 | 0.385 |
Price($) | Vol. | No. |
---|---|---|
0.410 | 453154 | 12 |
0.415 | 198911 | 12 |
0.420 | 287610 | 10 |
0.425 | 71800 | 2 |
0.430 | 259082 | 15 |
Last trade - 15.11pm 04/09/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |